Skip to content

Pressure Supporting Ventilation and EEG-guided Emergence for Free of Unwanted Complications

Pressure Supporting Ventilation and Electroencephalography-guided Extubation for Free of Unwanted compLications (PEACEFUL): a Randomised Controlled Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06165562
Enrollment
120
Registered
2023-12-11
Start date
2024-01-05
Completion date
2024-12-30
Last updated
2024-03-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid Surgery

Brief summary

This study aims to assess whether pressure supporting ventilation and electroencephalogram (EEG)-guided emergence can reduce airway complications after thyroid surgery compared with conventional emergence. Patients will be randomly assigned to either pressure supporting ventilation and EEG-guided emergence group (intervention group) or conventional emergence group (control group). Co-primary outcomes are the incidence of emergence coughing and lowest percutaneous oxygen saturation (SpO2) after emergence. Secondary outcomes included severity of emergence cough, emergence time, blood pressure and heart rate during emergence, Richmond Agitation-Sedation Scale (RASS) immediately after extubation and upon post-anesthesia care unit (PACU) arrival, incidence of desaturation during PACU stay, hoarseness, sore throat during PACU stay, duration of PACU stay, surgeon satisfaction regarding emergence process, postoperative pain score, and patient satisfaction score regarding emergence process.

Detailed description

Adult patients aged \< 40 years scheduled to undergo thyroid surgery will be screened for eligibility. Patients will be randomly allocate to either the intervention group or control group. * In the intervention group, pressure support ventilation will be applied from the start of subcutaneous suture until extubation. At the end of surgery, sevoflurane will be discontinued, and the attending anesthesiologist will perform tracheal extubation after observing the 'zipper opening' pattern on the EEG spectrogram, indicating the patient's recovery of consciousness. For safety reason, extubation will also be guided by the following processed EEG indices thresholds: 1. 95% spectral edge frequency (SEF) ≥ 23 2. Patient state index (PSI) ≥ 64 * In the control group, conventional full-awake extubation will be performed based on the routine practice of our institution. At the end of surgery, sevoflurane will be stopped, and the attending anesthesiologist will lead the emergence process, allowing the patient to breathe spontaneously and providing intermittent manual assistance if necessary. Extubation will be performed when the patient meets the following criteria: obeys commands such as eye-opening or hand-grip, tidal volume \> 5 ml/kg, end-tidal carbon dioxide \< 45 mmHg, spontaneous respiratory rate 10 to 20 breaths/min. In both groups, the Oxygen Reserve Index (ORi) will be monitored. Blinded investigator will assess the incidence of emergence coughing and the lowest SpO2 after emergence.

Interventions

PROCEDUREPSV

Pressure support ventilation applied from the start of subcutaneous suture until extubation.

PROCEDUREIntermittent Manual Assistance

Volume-controlled mode during surgery, with intermittent manual assistance from the end of surgery until extubation.

PROCEDUREEEG-Guidance

Extubation criteria based on EEG findings:Zipper opening pattern observed in the spectrogram 95% spectral edge frequency (SEF) ≥ 23 Patient state index (PSI) ≥ 64

PROCEDUREObey Command

Extubation criteria include obeying commands (eye-opening or handgrip).

PROCEDURESpontaneous Respiration

Extubation criteria include: Tidal volume \> 5 ml/kg End-tidal carbon dioxide (ETCO2) \< 45 mmHg Spontaneous respiratory rate (RR) 10 to 20 breaths/min

Sponsors

Gangnam Severance Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Investigator, Outcomes Assessor)

Masking description

Patients, medical staff responsible for measuring outcome variables, surgeons, and nurses in the recovery room and wards will be blinded. This blinding approach ensures that both medical staff and patients remain unaware of the assigned group throughout the study.

Intervention model description

Prospective, single-blinded, parallel-group, randomized clinical study

Eligibility

Sex/Gender
ALL
Age
19 Years to 39 Years
Healthy volunteers
No

Inclusion criteria

* Adult patients aged under 40 years who are scheduled to undergo thyroid surgery.

Exclusion criteria

* Patients scheduled for radical neck dissection * Patients scheduled for lymph node biopsy * Patients with an anticipated difficult airway * Patients experiencing difficulty during intubation * Patients with a fasting time not meeting institutional policy * Patients with a body mass index (BMI) greater than 30 kg/m² * Patients with sleep apnea * Pregnant or breastfeeding women * Patients unable to communicate

Design outcomes

Primary

MeasureTime frameDescription
Incidence of emergence coughingDuring the time period from sevoflurane cessation until 5 minutes after extubationIncidence of emergence coughing (defined as coughing during the time period from sevoflurane off until 5 minutes after extubation)
Lowest SpO2 after emergenceDuring the time period from sevoflurane cessation until post-anesthesia care unit (PACU) discharge, an average of 1 hourLowest SpO2 after emergence (defined as the lowest SpO2 value during the time period from sevoflurane off to post-anesthesia care unit (PACU) discharge)

Secondary

MeasureTime frameDescription
Time to leave operating roomDuring the time period from sevoflurane cessation until leaving operating room, an average of 30 minutesTime from sevoflurane cessation until leaving operating room
Severity of Emergence coughingDuring the time period from sevoflurane cessation until 5 minutes after extubation.The severity of emergence coughing will be assessed using the modified 4-point Minogue scale, with grades assigned as follows: grade 1 (none), grade 2 (mild), grade 3 (moderate), or grade 4 (severe). A higher score indicates a more severe cough.
Incidence and severity of coughing during PACU stayDuring the time period from PACU admission until PACU discharge, an average of 40 minutesIncidence and severity of coughing during PACU stay evaluated using a modified 4-point Minogue scale.
Emergence timeDuring the time period from sevoflurane cessation until tracheal extubation, an average of 20 minutesTime from sevoflurane cessation until tracheal extubation (minutes)
Incidence of endotracheal tube bitingDuring the time period from sevoflurane cessation until tracheal extubation, an average of 20 minutesBiting of the endotracheal tube; The investigator will observe whether the patient bites the endotracheal tube or not.
Hypoventilation after extubation (RR <8/min)During the time period from PACU admission until PACU discharge, an average of 40 minutesHypoventilation defined as Respiratory Rate \<8/min
Richmond Agitation-Sedation Scale (RASS) immediately after extubation and upon PACU arrivalRASS will be assessed at two time points; (1) immediately after tracheal extubation, and (2) immediately after PACU arrivalThe Richmond Agitation-Sedation Scale (range : +4 to -5)
Incidence of desaturation during PACU stayDuring the time period from PACU admission until PACU discharge, an average of 40 minutesIncidence of desaturation
HoarsenessDuring the time period from PACU admission until PACU discharge, an average of 40 minutesPatients will be specifically asked about the existence of a hoarse voice
Blood pressure during emergenceduring the time period from sevoflurane off until 5 minutes after extubationsystolic, diastolic, mean blood pressure (mmHg)
Duration of PACU stayDuring the time period from PACU admission until PACU discharge, an average of 40 minutesDuration of PACU stay (minutes)
Surgeon satisfaction regarding emergence process encompassing smoothness/safety/speedImmediately after the transfer of the patient from operating room to PACUSurgeon satisfaction regarding emergence process encompassing smoothness/safety/speed (0: totally unsatisfied, 10: totally satisfied)
Incidence of awareness with recallDuring the time period from PACU admission until PACU discharge, an average of 40 minutesPatients will be specifically asked whether they experienced intraoperative consciousness, explicit recall of intraoperative events, or the emergence process.
Pain score during PACU stayDuring the time period from PACU admission until PACU discharge, an average of 40 minutespain score assessed by numeric rating scale; from 0 (no pain) to 10 (worst pain)
Patient satisfaction score regarding emergence processDuring the time period from PACU admission until PACU discharge, an average of 40 minutes0: totally unsatisfied, 10: totally satisfied
Incidence of Postoperative hematomaAfter operation, through the hospitalization, an average of 3 days.hematoma formation
Incidence of wound dehiscenceAfter operation, through the hospitalization, an average of 3 days.dehiscence of the surgical wound
reoperationAfter operation, through the hospitalization, an average of 3 days.reoperation of thyroid surgery
Oxygen Reserve IndexDuring the period from sevoflurane cessation until PACU discharge, an average of 1 hourIndex of the patient's oxygen reserve, with a unit-less scale between 0.00 and 1.00.
Incidence and severity of sore throatDuring the time period from PACU admission until PACU discharge, an average of 40 minutesIncidence and severity of pain or irritation of the throat.
Heart rate during emergenceduring the time period from sevoflurane off until 5 minutes after extubationHeart rate (beats per minute)

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026